Cargando…
Multidimensional Cell-Free DNA Fragmentomic Assay for Detection of Early-Stage Lung Cancer
RATIONALE: Cell-free DNA (cfDNA) analysis holds promise for early detection of lung cancer and benefits patients with higher survival. However, the detection sensitivity of previous cfDNA-based studies was still low to suffice for clinical use, especially for early-stage tumors. OBJECTIVES: Establis...
Autores principales: | Wang, Siwei, Meng, Fanchen, Li, Ming, Bao, Hua, Chen, Xin, Zhu, Meng, Liu, Rui, Xu, Xiuxiu, Yang, Shanshan, Wu, Xue, Shao, Yang, Xu, Lin, Yin, Rong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Thoracic Society
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10161762/ https://www.ncbi.nlm.nih.gov/pubmed/36346614 http://dx.doi.org/10.1164/rccm.202109-2019OC |
Ejemplares similares
-
Enhanced Detection of Landmark Minimal Residual Disease in Lung Cancer Using Cell-free DNA Fragmentomics
por: Wang, Siwei, et al.
Publicado: (2023) -
Letter to the Editor: An ultra-sensitive assay using cell-free DNA fragmentomics for multi-cancer early detection
por: Bao, Hua, et al.
Publicado: (2022) -
Multidimensional fragmentomic profiling of cell-free DNA released from patient-derived organoids
por: Kim, Jaeryuk, et al.
Publicado: (2023) -
Multi-dimensional fragmentomic assay for ultrasensitive early detection of colorectal advanced adenoma and adenocarcinoma
por: Ma, Xiaoji, et al.
Publicado: (2021) -
Cell-Free DNA Fragmentomics in Liquid Biopsy
por: Ding, Spencer C., et al.
Publicado: (2022)